Award Winning Journalist Tracey Matisak to Host WVIA Mental Health Initiative Mind Over Matter Award winning journalist Tracey Matisak will host the WVIA and Geisinger presented mental health initiative Mind Over Matter. “We are excited to have Tracey guide conversations and increase awareness of mental illness prevention, treatment, and management in our area” said Ben Payavis II, WVIA’s Chief Content Officer. “Her extensive resume and inquisitive approach make her an ideal partner on this project to inform and engage the people of northeastern and central Pennsylvania.” “Mental health is a topic that, until recently, has not gotten the attention it deserves. While we have all been (rightly) focused on COVID-19, the anxiety and depression that have come along with it have created something of a secondary pandemic. I’m encouraged by those in the public eye who have courageously come forward to share their challenges and spark a national and long overdue conversation around mental health. It’s a topic that has touched my own life, and one that I’m looking forward to exploring with WVIA viewers through Mind Over Matter. My hope is that the series will encourage and challenge us all, and heighten our awareness and sensitivity to this important topic” said Matisak. With more than 30 years of major market television and radio experience, Tracey has anchored numerous special projects for WHYY-TV/PBS in Philadelphia; she also serves as a regular guest host on WHYY-FM’s Radio Times with Marty Moss-Coane. In addition, Tracey serves as moderator for the Philadelphia Speakers Series, where she has shared the stage with the likes of NBC’s Tom Brokaw, former British Prime Minister David Cameron, Equal Justice Initiative founder Bryan Stevenson and acclaimed filmmaker Ken Burns. Tracey is a frequent moderator for the Author Events series at the Free Library of Philadelphia, where she has interviewed former Defense Secretary Robert Gates, entertainer and civil rights activist Harry Belafonte, Huffington Post co-founder Arianna Huffington and Olympic gold medalist Simone Biles, among others. In addition, Tracey travels nationwide hosting live, interactive executive leadership webcasts for Skillsoft Corporation. In that capacity, she regularly interviews some of the most widely respected authors and speakers in the business world, including Daniel Pink, Seth Godin, John Maxwell and Angela Duckworth. Tracey is perhaps best known for her work in television news, having worked for 12 years at FOX 29, Philadelphia. There, she anchored the live morning show Good Day Philadelphia and served as an anchor and reporter for FOX 29’s Ten O’Clock News. She was also a contributor to the HGTV show Design Basics, and has served as a news anchor for a number of Philadelphia radio stations, including KYW Newsradio. A graduate of Temple University, Tracey taught for several years there as an adjunct instructor in the Klein College of Media and Communication. A winner of several local Emmy awards, Tracey was among the first to be inducted into Temple University’s School of Media and Communications Hall of Fame. She has also won the Sarah Award for Excellence in Broadcasting from the Association for Women in Communications and was named Communicator of the Year by the National Black MBA Association. Originally from Hazleton, PA, Tracey and her husband Daniel are the parents of three young adults; they live in suburban Philadelphia. Mind Over Matter is a yearlong initiative which includes programs and presentations created by WVIA. The series goal is to combat the stigma and increase awareness, prevention, treatment and management of a range of mental Illnesses. Like WVIA’s successful Battling Opioids series, this public health initiative aims to improve the mental and physical health of our community through a multi-platform approach that will include TV, radio, and digital content. Major funding for Mind Over Matter is provided by Geisinger. On Thursday, August 26th at 8pm the initiative will present Living with Alzheimer’s & Dementia, a program that explores the effects these diseases have on individuals, families and communities. To find more information and to learn more about Mind Over Matter visit wvia.org/mindovermatter.
Geisinger Launches Nursing Scholars Program for Employees Nurses make up the largest segment of the healthcare workforce and play critical roles in caring for patients. Now, Geisinger employees interested in a nursing career will have an easier path. By launching a new career development program, Geisinger will provide financial, educational and wellness support to its employees pursuing a career in nursing. The Geisinger’s Nursing Scholars Program eases the financial burden of nursing school and is open to any employee who’s worked with Geisinger for a year or more and isn’t already a registered nurse (RN) or provider. The program awards $40,000 in financial support with a 5-year work commitment as an inpatient nurse. The goal is to support 175 scholars per year by offering rolling admissions to the program. While supporting employee career and professional goals, the program will also mitigate a shortage of nurses across the organization and beyond. According to the U.S. Bureau of Labor Statistics, the nation needs 1.1 million new RNs by 2022 to avoid a nursing shortage. “There is a recruitment gap of approximately 300 registered nurses per year across the Geisinger system,” said Janet Tomcavage, chief nursing executive at Geisinger. “According to the Bureau of Labor Statistics’ Employment Projections, registered nursing is listed among the top occupations in terms of job growth through 2029. The RN workforce is expected to grow from 3 million in 2019 to 3.3 million in 2029, an increase of 7%. Community members across our footprint can join the Geisinger workforce and take advantage of this wonderful career advancement opportunity.” The program serves as an entry point into the healthcare profession for high school students and for anyone considering a career in nursing. Community members who are not Geisinger employees can apply for available positions within Geisinger and qualify for the program after only one year of employment. “We are aware that many of our employees are keen to pursue a nursing career but need additional support from us in achieving their dreams. This comprehensive nursing scholars’ program is designed to provide financial, educational and well-being support for Geisinger employees who would like to become registered nurses,” added Tomcavage. Geisinger will support the employee scholars in preparation to go back to school to set them up for success. Guidance in choosing a school and type of degree is available via an internal website and personal counseling. Those who wish to attend prep classes may do so through internally offered classes designed by Geisinger experts. Basic math, navigating online classes and work-life balance are some of the courses offered. While employees are in school, support via study groups, mentoring from Geisinger nurses and professional development opportunities will be available at Geisinger. “Studying while working is a huge undertaking and we understand that employees will need more than just financial support. We want to be able to support our employees’ well-being and provide them with help that they might need when preparing to go back to school. Geisinger’s Nursing Scholars Program is designed to motivate and support employees in achieving their best at work and at school,” said Rebecca Stoudt, associate dean of nursing student education at Geisinger. Geisinger partners with various nursing schools across its footprint, and has created easy access to healthcare for many Pennsylvania communities. The Geisinger Career Center, a recruitment and career services hub, offers community members and Geisinger employees the chance to make a difference through available job opportunities in the health system. Beyond the physical career center, located at 529 Mill St. in Danville, anyone interested can make virtual or phone consultations to learn about Geisinger careers. Candidates can speak with a Geisinger representative about open positions, and current Geisinger employees can learn more about professional development resources and events. Open positions at Geisinger are also listed at jobs.geisinger.org. To find out more about the career center or to make an appointment, call 877-564-6447 or email GeisingerCareers@geisinger.edu.
Geisinger Invests in Pittston Township Healthplex Geisinger has announced the development of an $80 million outpatient facility that will make better health easier for residents of northeastern Pennsylvania by improving availability and convenience of a variety of in-demand health services — from surgery to eye care. Centrally located between Scranton and Wilkes-Barre, the 124,000 square-foot Geisinger Healthplex CenterPoint will house nine clinical suites providing services in surgery and endoscopy, orthopaedics, urology, ophthalmology and retail eyewear, laboratory and imaging, and a hybrid medical and orthopaedic ConvenientCare. The healthplex will be located at 1201 Oak St., Pittston Township, previously the site of a Walmart. Situated near junctions of state Route 315, Interstate 81 and the Pennsylvania Turnpike, the facility is a short trip from either city. Designed to bring together services that complement each other, such as diagnostic imaging and orthopaedics, the healthplex will reduce the need for patients to go to different facilities for related appointments. It will have ample, ground-level parking, multiple entry points and will be reachable by public transportation. The project, expected to be complete by summer 2022, will create 154 jobs and is the latest in a line of Geisinger investments totaling more than $200 million in Luzerne County since the beginning of 2019. Each investment has been dedicated to expanding services, providing the latest technology and advancements in treatment, and bringing world-class care closer to home for people living in northeastern Pennsylvania. The healthplex will allow Geisinger to offer more appointments in the services provided and to hire new providers, which means patients will experience shorter wait times between scheduling an appointment and being seen by a provider. “When we looked at the services needed by our patients here in Luzerne and Lackawanna counties, we realized we were limited by the space we had available,” said Ron Beer, chief administrative officer of Geisinger’s northeast region. “This location makes care more accessible to our friends and neighbors, because it’s about as centralized between Scranton and Wilkes- Barre as it can be, truly making it easier for our patients and members in both counties to get the care they need more quickly.” Geisinger Healthplex CenterPoint will offer treatment options unique to the region. Bolstering a wide range of sports medicine, hand, and foot and ankle services, the orthopaedics team will perform arthroscopic hip procedures and wide awake local anesthesia no tourniquet (WALANT) procedures, which can treat conditions like carpal tunnel syndrome and tendonitis and reduce recovery times. A complete subspecialty eye-care program will feature ophthalmic providers capable of delivering virtually any service a patient may need, including neuro ophthalmology care and pediatric ophthalmology care, which are currently limited in Luzerne and Lackawanna counties. The team will also perform LASIK surgery, a first for Geisinger in the northeast region. Extended hours of operation will be available for diagnostic and by-appointment or walk-in ConvenientCare services, and amenities will include a central café and atrium with outdoor green space and seating. Modern design will create a bright, inviting atmosphere designed for patient comfort, and facial recognition technology will be available for easy check-in. “Geisinger Healthplex CenterPoint will offer distinctive, convenient care to the people of northeastern Pennsylvania,” Beer said. “Along with expanded services, we’re proud that our growth means more employment opportunities for local residents. We’re also excited to be renovating a space that was a popular place of commerce for the community. What was a frequented place of business will now be an easy-to-reach destination for exceptional care.” Investments in Luzerne County since January 2019: January 2019: $3.1 million, 8,000 square-foot inpatient wing opens at Geisinger South Wilkes-Barre with 14 private rooms for patients with medical and surgical needsMay 2019: $22 million Central Utility Plant completed at Geisinger Wyoming ValleyMedical Center, increasing utility capacity for the campus, which paves the way for future service growth, and decreasing energy consumption by 40 percentAugust 2019: $3 million 65 Forward Health Center opens in Kingston, bringing concierge-style primary care to Geisinger members 65 and olderMarch 2020: $6.5 million installation of CyberKnife S7 technology for targeted radiation therapy at Geisinger Wyoming Valley Medical CenterJuly 2020: Construction begins on $80 million renovation and expansion of GeisingerWyoming Valley Medical Center and the Frank M. and Dorothea Henry Cancer CenterOctober 2020: $3 million 65 Forward Health Center opens in downtown Wilkes-BarreNovember 2020: $3.3 million 65 Forward Health Center opens in West Hazleton
Walk-in, by Appointment COVID-19 Vaccines Remain Available at Geisinger Geisinger continues to offer the COVID-19 vaccine to our neighbors at our four vaccine centers and select Geisinger Pharmacy locations. Walk-in COVID-19 vaccinations will be available: Wednesday, Aug. 4, at the Geisinger Lewistown Hospital Vaccine Center, 400 Highland Ave. Ext., Lewistown, from 9 a.m. to 3:30 p.m.Thursday, Aug. 5, at Geisinger Jersey Shore Hospital, 1020 Thompson St., Jersey Shore, from 9 a.m. to 3:30 p.m.Friday, Aug. 6, at the Geisinger Hughes Center Vaccine Center, 9 Stearns Lane, Danville, from 9 a.m. to 3:30 p.m.Friday, Aug. 6, at the Geisinger CenterPoint Vaccine Center, 300 Keystone Ave., Pittston, from 9 a.m. to 3:30 p.m. In addition to appointments and walk-in times at our vaccine centers, by-appointment COVID-19 vaccines are available at select Geisinger Pharmacy locations, including Dallas, Danville, Lewistown, Lock Haven, Mount Pocono, Pottsville, State College and Scranton. Geisinger is offering the Pfizer BioNTech COVID-19 vaccine at all locations, which is a two-dose vaccine administered 21 days apart. The vaccines are available to anyone age 12 and over, but those under 18 years old must have a parent or legal guardian with them during vaccination. Appointments for a vaccine at one of the vaccine centers or a Geisinger Pharmacy can be made through myGeisinger or by calling 570-284-3657. To check on additional walk-in vaccine days and times, and for more information about the COVID-19 vaccine, visit geisinger.org/COVIDVax. As a reminder, masks are required for all patients and visitors (regardless of vaccination status) in all Geisinger buildings.
Geisinger Launches On-Demand Telehealth Visits When you need care right away but it’s not an emergency, you can now see a Geisinger urgent care provider without leaving home. On-demand virtual visits are available for conditions typically seen at Geisinger’s ConvenientCare urgent care centers. These include cold and flu symptoms, allergies, rashes, headaches, insect bites, sinus infections and urinary tract infections. Providers can assess your symptoms virtually and provide care, referrals and/or prescriptions without having to see you in the clinic. “Virtual on-demand visits add another level of convenience for Geisinger patients who need to see a provider quickly,” said David Fletcher, Geisinger’s associate vice president for telehealth. “Geisinger’s telemedicine capabilities provide patients with the care they need in the comfort of their homes.” If you’re a Geisinger patient, you can access on-demand virtual care at geisinger.org/virtualcare, via the symptom checker feature of Geisinger.org’s Virtual Assistant, or through the myGeisinger portal at geisinger.org/mygeisinger. On-demand visits are available Monday through Friday, 9 a.m. to 7 p.m., and 8 a.m. to 5 p.m. on weekends. The use of telehealth has increased tremendously during the COVID-19 pandemic, and Geisinger now offers telehealth visits for primary care, urgent care and 72 specialties. For more information about telehealth at Geisinger, or to see a demo, visit geisinger.org/telemedicine.
COVID-19 Vaccines Now Available at Select Geisinger Pharmacy Locations Geisinger continues to make it easier to get your COVID-19 vaccine — they’re now available at select Geisinger Pharmacy locations in central and northeastern Pennsylvania. You can schedule your vaccine at one of eight pharmacy locations, which are conveniently located in community medicine and multi-specialty offices. Appointments for a COVID-19 vaccine can be made through myGeisinger or by calling 570-284-3657. The site pharmacist will administer vaccines to those 12 and older, with weekday appointments available. The eight Geisinger Pharmacy locations offering the vaccines are: Geisinger Dallas, 114 Lt. Michael Cleary Drive, DallasGeisinger Healthplex State College, 132 Abigail Lane, Port MatildaGeisinger Healthplex Woodbine (Danville), 16 Woodbine Lane, DanvilleGeisinger Lewistown Clinic, 21 Geisinger Lane, LewistownGeisinger Lock Haven, 68 Spring St., Lock HavenGeisinger Mount Pleasant (Scranton), 531 Mt. Pleasant Drive, ScrantonGeisinger Mount Pocono, 126 Market Way, Mount PoconoGeisinger Pottsville, 529 Terry Reiley Way, Pottsville “With the continued rise of COVID-19 variants across the country, like the Delta variant, we’re happy to be able to expand our abilities to provide the COVID-19 vaccines at these pharmacy locations,” said Jenny Plummer, PharmD, director of retail and mail order pharmacy at Geisinger. “Offering the vaccine in our pharmacies located at community medicine sites makes it even easier for our neighbors to get a vaccine close to home.” Geisinger is offering the Pfizer BioNTech COVID-19 vaccine at all locations, which is a two-dose vaccine administered 21 days apart. Anyone under 18 years old must have a parent or legal guardian with them during vaccination. Geisinger continues to offer by-appointment and walk-in COVID-19 vaccination at Geisinger Philipsburg and at its vaccine centers in Danville, Jenkins Township, Jersey Shore and Lewistown. As with the Geisinger Pharmacy locations, you can make an appointment at one of these locations through myGeisinger or by calling 570-284-3657. To check on walk-in vaccine days and times, and for more information about the COVID-19 vaccine, visit geisinger.org/COVIDVax. As a reminder, masks are required for all patients and visitors (regardless of vaccination status) in all Geisinger buildings.
Geisinger Continuing Walk-In COVID-19 Vaccines this Week Geisinger continues to offer walk-in and by-appointment COVID-19 vaccine events this week at its four vaccine centers. Walk-in COVID-19 vaccinations will be available: Thursday, July 8, at Geisinger Jersey Shore Hospital, 1020 Thompson St., Jersey Shore, from 9 a.m. to 3:30 p.m.Friday, July 9, at the Geisinger Hughes Center Vaccine Center, 9 Stearns Lane, Danville, from 9 a.m. to 3:30 p.m.Friday, July 9, at the Geisinger CenterPoint Vaccine Center, 300 Keystone Ave., Pittston, from 9 a.m. to 3:30 p.m. In addition to the vaccine centers, COVID-19 vaccines are available by appointment at Geisinger Philipsburg in Centre County. Geisinger is offering the Pfizer BioNTech COVID-19 vaccine at all locations, which is a two-dose vaccine administered 21 days apart. The vaccines are available to anyone age 12 and over, but those under 18 years old must have a parent or legal guardian with them during vaccination. If needed, members of Geisinger’s pediatric team will be on hand to answer questions and to assist with the vaccinations. Appointments for a vaccine at Geisinger Philipsburg or at one of the vaccine centers can be made through myGeisinger or by calling 570-284-3657. To check on additional walk-in vaccine days and times, and for more information about the COVID-19 vaccine, visit geisinger.org/COVIDVax.
Two Geisinger Hospitals Ranked Among Newsweek’s World’s Best Smart Hospitals Geisinger Medical Center and Geisinger Wyoming Valley Medical Center made Newsweek’s 2021 list of World’s Best Smart Hospitals for their commitment to innovation and advancement in health care. Only 250 hospitals worldwide were recognized, and Geisinger Wyoming Valley and Geisinger Medical Center ranked 119th and 149th, respectively. They are among only seven hospitals recognized in Pennsylvania and just 89 hospitals selected in the United States. Both medical centers are the only hospitals in their service areas to make the list, and they’re the only two Pennsylvania hospitals recognized outside of Philadelphia or Pittsburgh. Ranked hospitals were evaluated on five criteria: digital surgery, digital imaging, artificial intelligence (AI), telehealth and electronic medical records. More than 13,000 votes from hospital managers and health care professionals with backgrounds in health care technology were considered, and every nominated hospital was thoroughly researched and validated by a team of analysts at Newsweek. Geisinger has long embraced utilization of technology to improve quality of care, catalyze research, and make communication with providers and use of services easier for the patients and members it serves. Robotic-assisted surgeries allow a higher degree of precision, smaller incisions, less scarring, less pain and discomfort, and the ability to treat areas difficult to reach with the human hand. At Geisinger, the da Vinci Surgical System® is used for less-invasive general surgery, colorectal surgery, thoracic surgery, surgical oncology procedures, OBGYN procedures and urology surgery. Mako® robotic arm-assisted surgery is used to perform partial and total knee replacements and total hip replacements, and Geisinger is the sole provider of Mako joint replacement surgery in the region it serves. “We value the use of digital systems in our surgical procedures because we know more precise, less invasive surgery leads to better outcomes and shorter recovery times for our patients,” said Ron Beer, chief administrative officer for Geisinger’s northeast region. “We’re honored to be among Newsweek’s World’s Best Smart Hospitals, because it’s a reflection of our continued effort to provide the best possible care, closer to home, for our patients and members.” Advanced imaging is used in a variety of diagnostic and surgical procedures at Geisinger. These include the cardiac catheterization labs where severe heart attacks and other cardiovascular issues are identified and treated swiftly, and the Comprehensive Stroke Centers — namely Geisinger Medical Center and Geisinger Wyoming Valley — that care for patients with complex strokes and neurovascular conditions. A robust electronic medical record and advancements in AI and machine learning are at the heart of research initiatives to detect risk of conditions like atrial fibrillation (A-fib) and even death. An innovative ECG Analysis Platform to detect A-fib risk, developed by Tempus in collaboration with Geisinger, was granted Breakthrough Device Designation by the U.S. Food and Drug Administration earlier this year. Geisinger is also using AI to improve imaging accuracy, diagnosis and follow-up care. A collaboration between Geisinger and Medial EarlySign to predict hospital admissions and complications was recently named runner-up out of more than 300 entries in the Centers for Medicare & Medicaid Services AI Health Outcomes Challenge. Telemedicine has been a critical tool in some areas of care delivery for years at Geisinger, but the SARS-CoV-2 pandemic accelerated use of the technology across the system. Since March 2020, Geisinger has enhanced its capability to conduct telemedicine visits and now offers telehealth consultation in 72 specialties. “When the pandemic began, we expanded our telemedicine capacity to keep our patients safe by making sure they were able to keep their primary care and regular specialty appointments without exposure to COVID-19 infection,” said Megan Brosious, chief administrative officer in Geisinger’s central region. “We already knew telemedicine works, but we’ve learned it has more applications than we thought, has vast potential to reveal new and innovative ways of caring for our patients and members, and aligns with our vision of making better health easier for the communities we serve.”
Geisinger Names Dr. Christa Lese Martin Chief Scientific Officer Geisinger has named Christa Lese Martin, Ph.D., its chief scientific officer. Dr. Martin, the founding director of Geisinger’s Autism & Developmental Medicine Institute (ADMI), will lead Geisinger’s systemwide clinical research initiatives, including more than 500 research faculty and staff members specializing in precision health, genomics, data science, population health, implementation science, health services, bioethics, and clinical trials. “Our vision at Geisinger is to learn from every patient to maximize better health for all,” Dr. Martin said. “Geisinger has a long history—more than 100 years—of excellence in research, and I look forward to leading us into the next phase as we integrate our research discoveries into routine clinical care.” Dr. Martin brings extensive experience in clinical and research genetics to the role. Before joining Geisinger in 2013, she was an associate professor in the Department of Human Genetics at Emory University and operations director of Emory Genetics Clinical Laboratory. Throughout her career, her research has taken a “genetics-first” approach to neurodevelopmental and neuropsychiatric disorders, including autism, intellectual disability, and schizophrenia, with a goal of developing precision health-driven treatments. Under her leadership, Geisinger’s Autism & Developmental Medicine Institute has grown to serve more than 9,000 patients and their families, leveraging leading-edge clinical research to improve outcomes for patients with developmental conditions. She is also part of the leadership team for the MyCode Community Health Initiative, Geisinger’s groundbreaking precision health program. In 2018, she was named associate chief scientific officer (CSO) at Geisinger and has served as interim CSO since December. Dr. Martin has played a leading role in developing Geisinger as a learning health system, bridging research discoveries and clinical medicine and bringing precision health into everyday care. Today, Geisinger is home to more than 1,000 ongoing research studies, including clinical trials, and Geisinger faculty and staff published more than 750 papers and articles in 2020. The Research Institute receives more than $41 million in external funding annually. Dr. Martin received her Bachelor of Science degree from Penn State University and completed her Ph.D. in Human Genetics at the University of Pittsburgh. She completed postdoctoral training at the University of Chicago’s Department of Human Genetics, where she remained on faculty as an assistant professor and director of the Clinical Cytogenetics Laboratory before joining Emory University in 2004. Dr. Martin is a principal investigator of several National Institutes of Health-funded awards, including the Clinical Genome Resource (ClinGen) and Genes to Mental Health (G2MH) consortia. She serves on multiple national committees, including the American College of Medical Genetics and Genomics (ACMG) Secondary Findings Working Group, which she co-chairs. She is board certified by the American Board of Medical Genetics and Genomics (ABMGG) as a clinical genetics laboratory director. In 2019, she was invited to join the prestigious Carol Emmott Fellowship program for women leaders in healthcare.
Geisinger’s Karen Murphy Among ‘50 Most Influential Clinical Executives’ Karen Murphy, Ph.D., R.N., executive vice president, chief innovation officer and founding director of the Steele Institute for Health Innovation at Geisinger, has been selected as one of Modern Healthcare’s 50 Most Influential Clinical Executives for 2021, and has been named a 2021 Changemaker in Health by the Healthcare Information and Management Systems Society (HIMSS). Modern Healthcare’s annual list of the 50 Most Influential Clinical Executives recognizes leaders who are paving the way to better health through innovation, community service and achievements inside and outside of their respective organizations. Murphy was recognized for the Steele Institute’s leading role in Geisinger’s response to the COVID-19 pandemic, including early contact tracing efforts, automation and vaccine distribution. Murphy and her team also used the pandemic as an opportunity to reimagine how care could and should be delivered in the future. This year’s class includes Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention. The inaugural HIMSS Changemaker in Health awards recognize 11 inspiring healthcare executives who challenge the status quo in their journeys to build a brighter health future. The awards celebrate innovative individuals as they lead change in their pursuit to improve care by harnessing the power of information and technology. Awardees were chosen by public online voting. “I am honored and humbled to be selected for these awards among my colleagues,” Dr. Murphy said. “Every day I’m fortunate to work with an incredible team of transformational and innovative people in an organization that inspires us to build a better future for our patients and communities.” Under Dr. Murphy’s direction, Geisinger’s Steele Institute is making health easier by developing leading-edge solutions that slow rising costs, improve quality and increase access to healthcare. Working with teams in digital transformation, robotic process automation, machine learning, behavioral economics and data enterprise, the Steele Institute builds solutions to improve overall health, patient experience, care delivery and affordability. Most recently, the Steele Institute launched ConnectedCare365, an innovative care delivery model for patients with chronic diseases like diabetes, heart failure and hypertension. Currently a pilot program, this first-of-its-kind virtual care delivery platform uses remote patient monitoring, artificial intelligence and powerful data analysis tools to improve patient outcomes. Throughout her career, Dr. Murphy has worked to improve and transform healthcare delivery in the public and private sectors. Before joining Geisinger, she served as Pennsylvania’s secretary of health, addressing the most significant health issues facing the state, including developing an innovative payment and delivery model for rural hospitals. Prior to her role as secretary, Dr. Murphy served as director of the State Innovation Models Initiative at the Centers for Medicare and Medicaid Services, and as president and chief executive officer of Moses Taylor Health Care System. For more information about Geisinger’s Steele Institute for Health Innovation, visit geisinger.org/innovation-steele-institute.
